Arrowstreet Capital’s Celularity CELU Stock Holding History

Arrowstreet Capital’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,919	Closed	-$195K	–	1615
2021 Q2	$195K	Sell	1,919 -18,667	-91%	-$1.89M	﹤0.01%	1787
2021 Q1	$2.08M	Buy	20,586 +2,805	+16%	+$288K	﹤0.01%	1556
2020 Q4	$1.96M	Buy	17,781 +4,854	+38%	+$516K	﹤0.01%	1603
2020 Q3	$1.36M	Buy	+12,927	New	+$1.34M	﹤0.01%	1719

Other funds holding CELU

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Arrowstreet Capital's CELU Position: Q3 2021 in Review

Arrowstreet Capital sold out of Celularity (CELU) in Q3 2021, closing a stake of 1,919 shares — an estimated $195K sold.

Arrowstreet Capital first reported a position in CELU in Q3 2020 and held it in 4 quarters. The position peaked at $2.08M in Q1 2021. 21 funds tracked by Wall St. Rank hold CELU as of Q3 2021.

Arrowstreet Capital reported no remaining Celularity position as of Q3 2021 after selling out during the quarter.
Arrowstreet Capital sold 1,919 Celularity shares in Q3 2021, an estimated $195K.
Arrowstreet Capital first reported a position in Celularity in Q3 2020 and held it in 4 quarters.
Arrowstreet Capital's Celularity position peaked at $2.08M in Q1 2021.
21 funds tracked by Wall St. Rank held Celularity as of Q3 2021.

Based on Arrowstreet Capital's 13F filing for Q3 2021, filed 12 Nov 2021.